Abstract
Nanoparticles in contact with proteins form a “corona” of proteins adsorbed on the nanoparticle surface. Subsequent biological responses are then mediated by the adsorbed proteins rather than the bare nanoparticles. The use of nanoparticles as nanomedicines and biosensors would be greatly improved if researchers were able to predict which specific proteins will adsorb on a nanoparticle surface. We use a recently developed automated workflow with a liquid handling robot and low-cost proteomics to determine the concentration and composition of the protein corona formed on carboxylate-modified iron oxide nanoparticles (200 nm) as a function of incubation time and serum concentration. We measure the concentration of the resulting protein corona with a colorimetric assay and the composition of the corona with proteomics, reporting both abundance and enrichment relative to the fetal bovine serum (FBS) proteins used to form the corona. Incubation time was found to be an important parameter for corona concentration and composition at high (100% FBS) incubation concentrations, with only a slight effect at low (10%) FBS concentrations. In addition to these findings, we describe two methodological advances to help reduce the cost associated with protein corona experiments. We have automated the digest step necessary for proteomics and measured the variability between triplicate samples at each stage of the proteomics experiments. Overall, these results demonstrate the importance of understanding the multiple parameters that influence corona formation, provide new tools for corona characterization, and advance bioanalytical research in nanomaterials.
Similar content being viewed by others
References
Fleischer CC, Payne CK. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res. 2014;47:2651–9.
Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41:2780–99.
Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7:779–86.
Nienhaus K, Nienhaus GU. Towards a molecular-level understanding of the protein corona around nanoparticles — recent advances and persisting challenges. Curr Opin Biomed Eng. 2019;10:11–22.
Kobos L, Shannahan J. Biocorona-induced modifications in engineered nanomaterial-cellular interactions impacting biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:e1608.
Tomak A, Cesmeli S, Hanoglu BD, Winkler D, Oksel KC. Nanoparticle-protein corona complex: understanding multiple interactions between environmental factors, corona formation, and biological activity. Nanotoxicology. 2021;15:1331–57.
Abarca-Cabrera L, Fraga-Garcia P, Berensmeier S. Bio-nano interactions: binding proteins, polysaccharides, lipids and nucleic acids onto magnetic nanoparticles. Biomater Res. 2021;25:1–18.
Cai R, Chen C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv Mater. 2019;31:e1805740.
Payne CK. A protein corona primer for physical chemists. J Chem Phys. 2019;151:130901.
Docter D, Strieth S, Westmeier D, Hayden O, Gao M, Knauer SK, et al. No king without a crown — impact of the nanomaterial-protein corona on nanobiomedicine. Nanomedicine. 2015;10:503–19.
Frtus A, Smolkova B, Uzhytchak M, Lunova M, Jirsa M, Kubinova S, et al. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: a road from failure to success in clinical applications. J Control Release. 2020;328:59–77.
Ke PC, Lin S, Parak WJ, Davis TP, Caruso F. A decade of the protein corona. ACS Nano. 2017;11:11773–6.
Hamad-Schifferli K. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine. Nanomedicine. 2015;10:1663–74.
Wheeler KE, Chetwynd AJ, Fahy KM, Hong BS, Tochihuitl JA, Foster LA, et al. Environmental dimensions of the protein corona. Nat Nanotechnol. 2021;16:617–29.
Wang D, Saleh NB, Byro A, Zepp R, Sahle-Demessie E, Luxton TP, et al. Nano-enabled pesticides for sustainable agriculture and global food security. Nat Nanotechnol. 2022;17:347–60.
Deng D, Li Y, Xue J, Wang J, Ai G, Li X, et al. Gold nanoparticle-based beacon to detect STAT5b mRNA expression in living cells: a case optimized by bioinformatics screen. Int J Nanomedicine. 2015;10:3231–44.
Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6:12–21.
Carrillo-Carrion C, Carril M, Parak WJ. Techniques for the experimental investigation of the protein corona. Curr Opin Biotechnol. 2017;46:106–13.
Jayaram DT, Pustulka SM, Mannino RG, Lam WA, Payne CK. Protein corona in response to flow: effect on protein concentration and structure. Biophys J. 2018;115:209–16.
Pisani C, Gaillard JC, Dorandeu C, Charnay C, Guari Y, Chopineau J, et al. Experimental separation steps influence the protein content of corona around mesoporous silica nanoparticles. Nanoscale. 2017;9:5769–72.
Hoang KNL, Wheeler KE, Murphy CJ. Isolation methods influence the protein corona composition on gold-coated iron oxide nanoparticles. Anal Chem. 2022;94:4737–46.
Poulsen KM, Pho T, Champion JA, Payne CK. Automation and low-cost proteomics for characterization of the protein corona: experimental methods for big data. Anal Bioanal Chem. 2020;412:6543–51.
Zarei M, Aalaie J. Profiling of nanoparticle-protein interactions by electrophoresis techniques. Anal Bioanal Chem. 2019;411:79–96.
Findlay MR, Freitas DN, Mobed-Miremadi M, Wheeler KE. Machine learning provides predictive analysis into silver nanoparticle protein corona formation from physicochemical properties. Environ Sci Nano. 2018;5:64–71.
Ban Z, Yuan P, Yu F, Peng T, Zhou Q, Hu X. Machine learning predicts the functional composition of the protein corona and the cellular recognition of nanoparticles. Proc Natl Acad Sci U S A. 2020;117:10492–9.
Ouassil N, Pinals Rebecca L, Del Bonis-O’Donnell Jackson T, Wang Jeffrey W, Landry Markita P. Supervised learning model predicts protein adsorption to carbon nanotubes. Sci Adv. 2022;8:eabm0898.
Blume JE, Manning WC, Troiano G, Hornburg D, Figa M, Hesterberg L, et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nat Commun. 2020;11:3662.
Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–5.
Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367–72.
Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11:2301–19.
cRAP protein sequences: the global proteome machine; 2012. Available from: https://www.thegpm.org/crap/index.html. Accessed 27 Apr 2022.
Bruckner M, Simon J, Jiang S, Landfester K, Mailander V. Preparation of the protein corona: how washing shapes the proteome and influences cellular uptake of nanocarriers. Acta Biomater. 2020;114:333–42.
Docter D, Distler U, Storck W, Kuharev J, Wunsch D, Hahlbrock A, et al. Quantitative profiling of the protein coronas that form around nanoparticles. Nat Protoc. 2014;9:2030–44.
Simon J, Kuhn G, Fichter M, Gehring S, Landfester K, Mailander V. Unraveling the in vivo protein corona. Cells. 2021;10:132.
Kastan Jonathan P, Dobrikova Elena Y, Bryant Jeffrey D, Gromeier M. CReP mediates selective translation initiation at the endoplasmic reticulum. Sci Adv. 2020;6:eaba0745.
Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–50.
Fleischer CC, Payne CK. Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B. 2012;116:8901–7.
Doorley GW, Payne CK. Nanoparticles act as protein carriers during cellular internalization. Chem Commun. 2012;48:2961–3.
Hill A, Payne CK. Impact of serum proteins on MRI contrast agents: cellular binding and T2 relaxation. RSC Adv. 2014;4:31735–44.
Doorley GW, Payne CK. Cellular binding of nanoparticles in the presence of serum proteins. Chem Commun. 2011;47:466–8.
Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol. 2013;8:772–81.
Alkilany AM, Lohse SE, Murphy CJ. The gold standard: gold nanoparticle libraries to understand the nano–bio interface. Acc Chem Res. 2013;46:650–61.
Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc. 2011;133:2525–34.
Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DW, et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano. 2014;8:2439–55.
Runa S, Lakadamyali M, Kemp ML, Payne CK. TiO2 nanoparticle-induced oxidation of the plasma membrane: importance of the protein corona. J Phys Chem B. 2017;121:8619–25.
Jayaram DT, Runa S, Kemp ML, Payne CK. Nanoparticle-induced oxidation of corona proteins initiates an oxidative stress response in cells. Nanoscale. 2017;9:7595–601.
Partikel K, Korte R, Mulac D, Humpf HU, Langer K. Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles. Beilstein J Nanotechnol. 2019;10:1002–15.
Grafe C, Weidner A, Luhe MV, Bergemann C, Schacher FH, Clement JH, et al. Intentional formation of a protein corona on nanoparticles: serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction. Int J Biochem Cell Biol. 2016;75:196–202.
Vroman L, Adams A, Fischer G, Munoz P. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood. 1980;55:156–9.
Lima T, Bernfur K, Vilanova M, Cedervall T. Understanding the lipid and protein corona formation on different sized polymeric nanoparticles. Sci Rep. 2020;10:1129.
Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano. 2010;4:3623–32.
Pisani C, Gaillard JC, Odorico M, Nyalosaso JL, Charnay C, Guari Y, et al. The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome. Nanoscale. 2017;9:1840–51.
Dudzik D, Barbas-Bernardos C, Garcia A, Barbas C. Quality assurance procedures for mass spectrometry untargeted metabolomics. a review. J Pharm Biomed Anal. 2018;147:149–73.
Runa S, Khanal D, Kemp ML, Payne CK. TiO2 nanoparticles alter the expression of peroxiredoxin antioxidant genes. J Phys Chem C. 2016;120:20736–42.
Yu Q, Zhao L, Guo C, Yan B, Su G. Regulating protein corona formation and dynamic protein exchange by controlling nanoparticle hydrophobicity. Front Bioeng Biotechnol. 2020;8:210.
Strojan K, Leonardi A, Bregar VB, Krizaj I, Svete J, Pavlin M. Dispersion of nanoparticles in different media importantly determines the composition of their protein corona. PLoS ONE. 2017;12:e0169552.
Venerando R, Miotto G, Magro M, Dallan M, Baratella D, Bonaiuto E, et al. Magnetic nanoparticles with covalently bound self-assembled protein corona for advanced biomedical applications. J Phys Chem C. 2013;117:20320–31.
Sakulkhu U, Maurizi L, Mahmoudi M, Motazacker M, Vries M, Gramoun A, et al. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. Nanoscale. 2014;6:11439–50.
de Castro CE, Panico K, Stangherlin LM, Ribeiro CAS, da Silva MCC, Carneiro-Ramos MS, et al. The protein corona conundrum: exploring the advantages and drawbacks of its presence around amphiphilic nanoparticles. Bioconjug Chem. 2020;31:2638–47.
Zhang T, Li G, Miao Y, Lu J, Gong N, Zhang Y, et al. Magnetothermal regulation of in vivo protein corona formation on magnetic nanoparticles for improved cancer nanotherapy. Biomaterials. 2021;276:121021.
Wang Z, Hood ED, Nong J, Ding J, Marcos-Contreras OA, Glassman PM, et al. Combating complement’s deleterious effects on nanomedicine by conjugating complement regulatory proteins to nanoparticles. Adv Mater. 2022;34:e2107070.
Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Piovesana S, La Barbera G, et al. The liposome-protein corona in mice and humans and its implications for in vivo delivery. J Mater Chem B. 2014;2:7419–28.
Bigdeli A, Palchetti S, Pozzi D, Hormozi-Nezhad MR, BaldelliBombelli F, Caracciolo G, et al. Exploring cellular interactions of liposomes using protein corona fingerprints and physicochemical properties. ACS Nano. 2016;10:3723–37.
Saha K, Rahimi M, Yazdani M, Kim ST, Moyano DF, Hou S, et al. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano. 2016;10:4421–30.
Naidu PSR, Norret M, Smith NM, Dunlop SA, Taylor NL, Fitzgerald M, et al. The protein corona of PEGylated PGMA-based nanoparticles is preferentially enriched with specific serum proteins of varied biological function. Langmuir. 2017;33:12926–33.
Zhang H, Burnum KE, Luna ML, Petritis BO, Kim JS, Qian WJ, et al. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size. Proteomics. 2011;11:4569–77.
Acknowledgements
The authors thank Gustavo Sosa Macias, Judith Dominguez, and Nathan Rayens for helpful discussion. We thank the Duke University School of Medicine for the use of the Proteomics and Metabolomics Shared Resource, which provided proteomics service, with special thanks to Erik Soderblom and Greg Waitt for technical advice.
Funding
This study received funding from the NSF (CBET-1901579).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Poulsen, K.M., Payne, C.K. Concentration and composition of the protein corona as a function of incubation time and serum concentration: an automated approach to the protein corona. Anal Bioanal Chem 414, 7265–7275 (2022). https://doi.org/10.1007/s00216-022-04278-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-022-04278-y